Oculis Holding AG (OCS) Other Non-Current Liabilities (2023 - 2026)

Oculis Holding AG (OCS) recorded quarterly Other Non-Current Liabilities of $26.2 million in Q1 2026, up 44.81% quarter-over-quarter from $18.1 million in Q4 2025, and up 57.89% on a YoY basis from $16.6 million in Q1 2025.

Oculis Holding AG (OCS) Other Non-Current Liabilities (2023 - 2026) Analysis & Trends

Oculis Holding AG's Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $26.2 million for Q1 2026.

  • In Q1 2026, Other Non-Current Liabilities rose 57.89% year-over-year to $26.2 million; the TTM figure through Mar 2026 stood at $26.2 million (up 57.89% YoY), while the FY2025 annual figure was $18.1 million, down 20.06% from the prior year.
  • Other Non-Current Liabilities was $26.2 million for Q1 2026 at Oculis Holding AG, up from $18.1 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $26.2 million in Q1 2026 to a low of $426140.0 in Q4 2023.
  • Historically, Other Non-Current Liabilities has averaged $11.7 million across 4 years, with a median of $12.1 million in 2025.
  • The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities surged 5217.58% in 2024, then fell 20.06% in 2025.
  • A 4-year view of Other Non-Current Liabilities shows it stood at $426140.0 in 2023, then jumped by 5217.58% to $22.7 million in 2024, then fell by 20.06% to $18.1 million in 2025, then surged by 44.81% to $26.2 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $26.2 million (Q1 2026), $18.1 million (Q4 2025), and $15.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn -
7 Psyence Biomedical 229.39 Bn 229.38 Bn -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn
9 Abivax 90.15 Bn 90.15 Bn -
10 Oculis Holding AG 8.23 Bn 7.92 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 26.23 Mn
Dec 31, 2025 18.11 Mn
Sep 30, 2025 15.18 Mn
Jun 30, 2025 18.25 Mn
Mar 31, 2025 16.61 Mn
Dec 31, 2024 22.66 Mn
Sep 30, 2024 9.01 Mn
Jun 30, 2024 8.14 Mn
Mar 31, 2024 433,067.91
Dec 31, 2023 426,139.99
Sep 30, 2023 426,821.52
Jun 30, 2023 4.78 Mn